Arlenda
Desconocido
Inno4Vac: Innovations to accelerate vaccine development and manufacture
PHARMALEX BELGIUM
participó en un
H2020:
H2020-JTI-IMI2-2020-20-two-stage
Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado
2021-07-19 - 2027-02-28 | Financiado
EQIPD: European Quality In Preclinical Data
PHARMALEX BELGIUM
participó en un
H2020:
H2020-JTI-IMI2-2016-09-two-stage
Pharmaceutical industry, as well as basic science, depend on robust data and scientific rigor as key drivers for decision making, patent str...
2017-08-18 - 2021-09-30 | Financiado
2017-08-18 - 2021-09-30 | Financiado
* No se disponen de datos de la empresa actual.